Top

Published in:

16-07-2022 | Research Article

Anlotinib as third- or further-line therapy for short-term relapsed small-cell lung cancer: subgroup analysis of a randomized phase 2 study (ALTER1202)

Authors: Jianhua Shi, Ying Cheng, Qiming Wang, Kai Li, Lin Wu, Baohui Han, Gongyan Chen, Jianxing He, Jie Wang, Haifeng Qin, Xiaoling Li

Title: Anlotinib as third- or further-line therapy for short-term relapsed small-cell lung cancer: subgroup analysis of a randomized phase 2 study (ALTER1202)
Authors: Jianhua Shi
Ying Cheng
Qiming Wang
Kai Li
Lin Wu
Baohui Han
Gongyan Chen
Jianxing He
Jie Wang
Haifeng Qin
Xiaoling Li
Publication date: 16-07-2022
Publisher: Higher Education Press
Published in: Frontiers of Medicine / Issue 5/2022
Print ISSN: 2095-0217
Electronic ISSN: 2095-0225
DOI: https://doi.org/10.1007/s11684-021-0916-8